Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Editorial] False hope with the Right to Try Act

On Wednesday, May 30, US President Donald Trump signed the Right to Try Act, a law designed to remove the US Food and Drug Administration (FDA) from decisions on allowing patients to seek early access to experimental and unapproved drugs that have passed phase 1 trials. Advocates argue that streamlining the process will allow more people access, and perhaps allow lives to be extended or saved. Trump said that the new law could save “hundreds of thousands” of lives.